Is NKTX Worth Buying in 2026?

Nkarta, Inc. Common Stock

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-04-19

Here’s whether Nkarta, Inc. Common Stock (NKTX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.10% over 10 days); strong 1-year return of +98.3%; 3-month momentum positive (+70.1%); rising volume confirms the move (1.28x 30d avg). Concerns: RSI 84 — overbought, elevated pullback risk. Currently 0.4% off its 52-week high. Score: +6/7.

Ready to act on this? 📈 Trade on Webull

NKTX is in a confirmed uptrend, trading above both its 50-day ($2.31) and 200-day ($2.12) moving averages. With an RSI of 83.7, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +98.3% compares to +35.1% for SPY (beat the market by 63.2%).

$10,000 invested 1 year ago → $19,829 today
vs. S&P 500 (SPY) — same period beat market by 63.2%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($2.12)
Above 50-day MA ($2.31)
!RSI(14) neutral zone (30–70) — currently 83.7
Positive return (+98.3%)
Within 10% of period high (−0.4%)
Period Range $3.47
$1.63 $3.49
RSI (14) 83.7
0 · OversoldOverbought · 100

Key Metrics

Price$3.47
Period Return+98.3%
Period High$3.49
Period Low$1.63
Drawdown−0.4%
MA-50$2.31
MA-200$2.12
RSI (14)83.7
Avg Volume (30d)719K
vs. SPYbeat by 63.2%
Return Rank#220 of 996

Trade NKTX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers